126 related articles for article (PubMed ID: 7863469)
1. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma.
Shiozaki A; Niiya K; Higuchi F; Tashiro S; Arai T; Izumi R; Sakuragawa N
Thromb Res; 1994 Oct; 76(2):199-210. PubMed ID: 7863469
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I.
Matsuda J; Gohchi K; Tsukamoto M; Saitoh N; Asami K; Hashimoto M
Am J Hematol; 1993 Nov; 44(3):187-91. PubMed ID: 8213768
[TBL] [Abstract][Full Text] [Related]
4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
5. Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome.
Takeuchi R; Atsumi T; Ieko M; Amasaki Y; Ichikawa K; Koike T
Br J Haematol; 2002 Dec; 119(3):781-8. PubMed ID: 12437660
[TBL] [Abstract][Full Text] [Related]
6. Conformation of beta2glycoprotein I and its effect on coagulation.
Ninivaggi M; Kelchtermans H; Lindhout T; de Laat B
Thromb Res; 2012 Oct; 130 Suppl 1():S33-6. PubMed ID: 22925530
[TBL] [Abstract][Full Text] [Related]
7. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
8. Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V.
Itoh Y; Inuzuka K; Kohno I; Wada H; Shiku H; Ohkura N; Kato H
J Biochem; 2000 Dec; 128(6):1017-24. PubMed ID: 11098145
[TBL] [Abstract][Full Text] [Related]
9. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
[TBL] [Abstract][Full Text] [Related]
10. Immunization of a rabbit with beta 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies.
Kouts S; Wang MX; Adelstein S; Krilis SA
J Immunol; 1995 Jul; 155(2):958-66. PubMed ID: 7608571
[TBL] [Abstract][Full Text] [Related]
11. Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes.
Lutters BC; Meijers JC; Derksen RH; Arnout J; de Groot PG
J Biol Chem; 2001 Feb; 276(5):3060-7. PubMed ID: 11053420
[TBL] [Abstract][Full Text] [Related]
12. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
Oosting JD; Derksen RH; Entjes HT; Bouma BN; de Groot PG
Thromb Haemost; 1992 May; 67(5):499-502. PubMed ID: 1519207
[TBL] [Abstract][Full Text] [Related]
13. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
14. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
[TBL] [Abstract][Full Text] [Related]
15. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
Schousboe I; Rasmussen MS
Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
[TBL] [Abstract][Full Text] [Related]
17. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies.
Safa O; Esmon CT; Esmon NL
Blood; 2005 Sep; 106(5):1629-35. PubMed ID: 15890686
[TBL] [Abstract][Full Text] [Related]
19. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
20. Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro.
Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ
J Clin Pathol; 1993 Oct; 46(10):908-11. PubMed ID: 8227406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
